Anti-hyperglycemic effects of three medicinal plants in diabetic pregnancy: modulation of T cell proliferation by Akadiri Yessoufou et al.
Yessoufou et al. BMC Complementary and Alternative Medicine 2013, 13:77
http://www.biomedcentral.com/1472-6882/13/77RESEARCH ARTICLE Open AccessAnti-hyperglycemic effects of three medicinal
plants in diabetic pregnancy: modulation of T cell
proliferation
Akadiri Yessoufou1*, Joachim Gbenou2†, Oussama Grissa3†, Aziz Hichami4, Anne-Marie Simonin5, Zouhair Tabka3,
Mansourou Moudachirou2, Kabirou Moutairou1 and Naim A Khan5Abstract
Background: Populations in Africa mostly rely on herbal concoctions for their primarily health care, but so far
scientific studies supporting the use of plants in traditional medicine remain poor. The present study was
undertaken to evaluate the anti-hyperglycemic effects of Picralima nitida (seeds), Nauclea latifolia (root and stem)
and Oxytenanthera abyssinica (leaves) commonly used, in diabetic pregnancy.
Methods: Pregnant wistar rats, rendered diabetic by multiple low injections of streptozotocin, were treated with
selected plant extracts based on their antioxidant activities. Vitamin C concentrations, fatty acid compositions and
phytochemical analysis of plants extracts were determined. Effect of selected plant extracts on human T cell
proliferation was also analysed.
Results: All analysed plant extracts exhibited substantial antioxidant activities probably related to their content in
polyphenols. Picralima nitida exhibited the highest antioxidant capacity. Ethanolic and butanolic extracts of
Picralima nitida, butanolic extract of Nauclea latifolia and ethanolic extract of Oxytenanthera abyssinica significantly
decreased hyperglycemia in the diabetic pregnant rats. Butanolic extract of Picralima, also appeared to be the most
potent immunosuppressor although all of the analysed extracts exerted an immunosuppressive effect on T cell
proliferation probably due to their linolenic acid (C18:3n-3) and/or alkaloids content. Nevertheless, all analysed
plants seemed to be good source of saturated and monounsaturated fatty acids.
Conclusion: By having antioxidant, anti-hyperglycemic and immunosuppressive activities, these plants could be
good candidates in the treatment of diabetes and diabetic pregnancy.
Keywords: Medicinal plants, Diabetic pregnancy, Antioxidants, T-cell proliferation, Fatty acidsBackground
The prevalence of diabetes mellitus (DM) is increasing
across the world and in the year 2011 the World Health
Organization [1] estimated that over 346 million of people
live with DM worldwide. Nearly 80% of deaths due to DM
occur in low and middle income countries. Because of the
high cost of conventional treatments with synthetic drugs,
traditional treatment with plants becomes an alternative* Correspondence: yeskad2001@yahoo.fr
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distribution, and reproduction in any mediumoption for financially poor populations who may have
problems of accessibility to modern drugs. For these rea-
sons, the development of new therapies from plants that
are able to control diabetes mellitus is of great interest.
Several plants have been used by traditional and ancestral
medicine men in African countries for the treatment of
several pathologies including digestive disorders, weak-
ness, liver complaints, obesity, urinary troubles, diabetes,
skin infections, fever, diarrhoea and insomnia [2-6]. How-
ever, the use of some of the plants still suffers from the
lack of scientific evidence which may support their inclu-
sion in the treatment of certain diseases like diabetes. We
have recently investigated the role of crude extracts of dif-
ferent parts of Zizyphus lotus L (Desf.), a plant commonlytral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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diabetic properties, sedative, analgesic, anti-inflammatory
and hypoglycaemic activities [7,8], on human Tcell prolifer-
ation [9]. In the present study, we report the results of three
plants: Nauclea latifolia, Oxytenanthera abyssinica and
Picralima nitida commonly and traditionally used in Benin,
Africa by diabetic patients.
Nauclea latifolia belongs to Rubiaceae family and is a
small tree found in tropical areas in Africa. It is used in
traditional medicine to treat malaria, epilepsy, anxiety,
pain, fever [5,6]. Moreover, root stem of this plant is
traditionally and empirically used by diabetic patients in
Benin to manage their glycemia.
Oxytenanthera abyssinica (Gramineae), commonly
known as bamboo, is a plant found in tropical areas in
Africa. This plant has a short rhizome and a rapid
growth (over 20 mm per day) and can reach 10 m height
with 5 cm of diameter [10]. Traditionally, decoction of
plant leaves is used in the treatment of diabetes in
Senegal and Togo.
Picralima nitida (Stapf.) (Apocynaceae) is widely found
in Western Africa, from Côte d’Ivoire to Uganda and
further to south of Democratic Republic of Congo and
Cabinda region in Angola. Several studies have reported
that different parts of this plant (seeds, root, stem) possess
many properties and is used as an anti-malaria, antimicro-
bial, anti-inflammatory and analgesic [11,12]. Several re-
cent studies have also demonstrated anti-ulcer activity of
methanolic extract of the plant seeds [13]. Seeds of this
plant have, from time in memorial, been consumed by dia-
betic patients in some West African countries to control
their glycemia. While few studies have reported that
extract from the seeds of this plant did not possess
antidiabetic and hypoglycemic activities [14] in contrast,
other studies have proved the antidiabetic activity of the
seed extract in alloxan-induced diabetic animals [15,16].
Most of these studies cited above reported the activities
of plants in several pathologies. However, none of them
has investigated their efficacy in diabetes associated with
pregnancy. Convincing evidence has shown that diabetic
pregnancy, defined as either maternal pre-existing diabetes
(type 1 and type 2 diabetes) or gestational diabetes
mellitus (which occurs only during pregnancy), is associ-
ated with macrosomia. Indeed, we have previously demon-
strated, in many clinical and experimental studies, that
diabetes during pregnancy is an important risk factor for
fetal overnutrition and macrosomia, and for the develop-
ment of obesity and diabetes in adult offspring [17-22]. In
fact, experimental diabetes during pregnancy, induced by
a high single dose of streptozotocin, occurs by direct toxic
effects on pancreatic β-islet cells [23]. The fetal growth is
retarded, leading to fetal microsomia (low birth weight)
[23]. Postnatal development is also retarded, and the off-
spring remain small at adulthood; and they develop insulinresistance [23]. Streptozotocin, administered at low doses
during 5 consecutive days, induces mild type 1 diabetes,
following a T-lymphocyte-dependent process, an auto-
immune destruction of pancreatic β cells [24]. This model
of diabetes during pregnancy leads to macrosomia in off-
spring. Macrosomic (large-sized) offspring of diabetic
dams maintained an accelerated weight gain until adult-
hood [17-22].
Moreover, all forms of diabetic pregnancy have been
linked to a pathological role of immune system and in-
flammation [24-26] which implicates T-lymphocytes, the
principal mediators of immune-mediated pathologies.
Hence, an intervention on T cell activation would be a
valuable tool to disrupt disease progression. Since the
plants reported in this study have been shown to modu-
late different disorders, we then aim to investigate their
efficacy in diabetic pregnancy in rats and their action
through the modulation of T cell proliferation. We also
examine antioxidant capacity of the plant extracts, since
antioxidants have been reported to modulate immune
system [27].
Methods
Plant materials’ collection and extracts’ preparation
Plants were collected from the south-eastern part of Benin
(Abomey-Calavi, Adjarra, Agonvy in Departments of
Atlantic and Oueme) between half July to half August
2007 during the short dry season when the mean
temperature equals to 28 ± 2°C (Agence de Sécurité de la
Navigation Aérienne, Station de Dangbo). This period is
preceded by the great rain season (half March to half July).
The area belongs to hydromorphic lateritic soil on clay
sediments (reference: Carte pédologique de reconnais-
sance à 1/200,000 Feuille de Porto-Novo 1975, Benin)
and these plants adapt to this kind of soil. Plants were
identified by the Principal Botanist of National Herbarium
of Benin of University of Abomey-Calavi, where the
voucher specimens were deposited under following
numbers: Picralima nitida (Stapf.) Apocynaceae T & H
Durand: AP-1904-HNB; Nauclea latifolia Rubiaceae:
AP-2081-HNB and Oxytenanthera abyssinica Gramineae
(A. Rich) Munro: AP-2076-HNB.
Parts of plants including the seeds of Picralima nitida,
root and stem of Nauclea latifolia and leaves of
Oxytenanthera abyssinica were collected and used to pre-
pare different extracts as described elsewhere [28]. The
plant materials were dried at laboratory air-conditioned
temperature and stored in a dry place prior to use. Mate-
rials were reduced into powder and subjected to five con-
secutive liquid-liquid extractions to obtain five different
fractions. Briefly, 100 g of powder were suspended in
500 ml of ethanol 96% and mixed for 72 h. The collected
filtrate was evaporated under vacuum at 50°C to drive
away alcohol. The ethanolic extract (a) was obtained and
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extract was added to distilled water and diethyl-ether (vol-
ume/volume). This solution was macerated and showed
two phases: aqueous phase and ether phase. The ether
phase was evaporated under vacuum at 50°C to obtain
Ether-extract (b). The collected aqueous phase was added
to ethyl-acetate (volume/volume). The solution was mixed
and also showed two phases: aqueous and ethyl-acetate
phases. Ethyl-acetate-extract (c) was then obtained by
evaporating under vacuum at 50°C and the collected aque-
ous phase was also added with n-butanol. The solution
was mixed and also showed two phases: aqueous phase
and butanolic phase. The butanolic phase was then evapo-
rated under vacuum at 50°C in order to obtain butanolic
extract (d). The residual aqueous phase was then lyophi-
lized and constituted residual aqueous extract (e). All the
obtained extracts were then used for study.
Diabetes induction and animal treatment by plant
extracts
Female Wistar rats from 2 to 3 month old, weighing from
200 to 250 g, were obtained from IFA-CREDO (Abresle,
France). After 1 week of acclimation, animals were divided
into experimental groups. After mating, the first day of
gestation was estimated by the presence of spermato-
zoids in vaginal smears. Pregnant rats were housed indi-
vidually in wood chip-bedded plastic cages at constant
temperature (25°C) and humidity (60 ± 5%) with a 12-
hour light/dark cycle.
Each experimental group consisted of ten pregnant
rats. For diabetes induction, pregnant rats were rendered
diabetic by intraperitoneal administration of five low
doses of streptozotocin (20 mg/kg body weight, in 0.1 M
citrate buffer, pH 4.5), starting on the fifth day of gestation
(day5 to day9) [19-22,24,25]. Control pregnant animals
were injected with the vehicle alone and considered as a
control group.
Then, plant extracts diluted in sterile physiological sa-
line solution (NaCl 0.9%) were sterilized and filtrated
[filter 0.20 μm (Nalge Nunc International Corp., USA)]
and injected intraperitoneally for four consecutive days
to diabetic or control animals (25 mg/kg body weight),
from day12 to day15 of gestation. As positive controls,
one group of diabetic animals was injected with four
consecutive doses of insulin (0.75 U/kg body weight;
Actrapid Novo, Copenhagen, Denmark).
For the determination of glycemia during gestation ma-
ternal blood was collected after an overnight fasting on
day12 and day16 of gestation by cutting off the tip of the
tail and squeezing it gently. Fasting glycemia was mea-
sured using One Touch ULTRA WGlucometer (LifeScan,
Johnson and Johnson, USA). At delivery on day21 and
after overnight fasting, animals were anaesthetized with
pentobarbital (60 mg/kg body weight), as describedpreviously [19-22]. The abdominal cavity was opened, and
whole blood was drawn from the abdominal aorta. Plasma
was obtained by low-speed centrifugation (1000 g, 20 min)
and immediately used for glucose and vitamin C determi-
nations. The general guidelines for the care and use of
laboratory animals, recommended by the Council of
European Economic Communities, were followed. The
experimental protocol was approved by the Regional
Ethical Committee (Comité d’Ethique de l’Expérimentation
Animale of University of Bourgogne, Dijon, France; Re-
searcher Authorization number n °: 21 CAE 069)”.Determination of vitamin C concentration in plant
extracts and plasma
Total ascorbate (vitamin C) levels were determined in
lyophilised plant extracts (100 mg/ml in phosphate buff-
ered saline, pH 7.4) or in rat plasma on day21 (at deliv-
ery) using the method of Roe and Kuether [29] as
described below. After protein precipitation in extract
supernatant or in plasma with 10% trichloroacetic acid
and centrifugation, the supernatant (500 μl) was mixed
with 100 μl of DTC reagent (9 N sulfuric acid containing
2,4-dinitrophenylhydrazine 3%, thiourea 0.4% and cop-
per sulfate 0.05%) and incubated at 37°C for 3 h. After
the addition of 750 μl of 65% (v/v) sulfuric acid, the ab-
sorbency was recorded at 520 nm.Antioxidant capacity of plant extracts
Plant extract resistance to free radical aggression was used
to determine the capacity of red blood cells (RBCs) to with-
stand free radical-induced haemolysis and was measured
according to the method of Blache and Prost [30] who have
demonstrated that if at least one component of the
antiradical detoxification system (antioxidants, enzymes) is
impaired a shift of the haemolysis curve is observed toward
shorter times. Briefly, washed RBCs were diluted (1:40, v/v)
with anti-radical resistance [(Kit Radicaux Libres (KRLW;
Kirial International SA, Couternon, France)] buffer (300
mOsmol/kg) and 50 μL of RBCs suspension was assayed in
a 96-well microplate coated with a free radical generator
(GRL, Kirial International SA). The kinetic of RBCs resist-
ance to haemolysis in the presence of plant extract solu-
tions (1 mg/ml), was determined at 37°C by continuous
monitoring of changes in absorbance at 620 nm. The time
to reach 50% of total haemolysis was retained for group
comparisons.Phytochemical analysis of the extracts
Chemical compounds of the total brut extracts of plants
(Table 1) were investigated using the methods of
Houghton and Amala [31] based on colorimetric reac-
tions and differential precipitations.
Table 1 Phytochemical composition of plants
Chemical
compounds class Test







Alkaloids General test: Dragendorff reagent +++ - +++
Extraction: Mayer reagent +++ ++ +++
Gallic tannins Saturation of Na acetate + a few drips of FeCl3, 1% + +++ ++
Cathechic tannins Stiasny reagent - - +++
Flavonoids Shinoda reagent (cyanidine reaction) - ++ ++
Anthocyanes Adding some drips of HCl 5% to 1 mL of decocted +
alcalinisation (with drips of ammoniac 50%)
- + +
Leucoanthocyanes Shinoda reagent (chlorhydric alcohol) - - +
Quinonic derivates Born-Trager reaction Concentrated HCl ++ + -
Diluted HCl +++ ++ -
Saponosides Foam index (FI) of diluted aqueous decoction (positive
if FI≥ 100, meaning foam height≥ 1 cm)
+++ - +
(FI > 1 cm) (FI < 1 cm) (FI = 1 cm)
Triterpenoids Liebermann-Buchard reaction (acetic anhydride-sulfuric
acide 50 :1)
- - -
Steroids Kedde reaction (dinitrobenzoic acid 2% in ethanol +
NaOH (1 N) 1:1)
- - +++
Cardenolids RAYMOND reaction (Dinitrobenzene 1% in ethanol +
NaOH 20%)
- - -
Cyanogenic derivates Grignard reaction (soaked paper with picric acid 5% - - -
Mucilages Viscosity study (in absolute ethanol) +++ ++ -
Chemical compounds of total brut extract of selected parts of plants. The phytochemical analysis was performed as described in Methods section. (+++) too high,
(++) high (+) low: indicates the presence of the compounds in the plants; (−) indicates the absence of compound in plants.
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Human (Jurkat) T-cells were routinely cultured in
RPMI-1640 medium supplemented with 10% foetal calf
serum, 2 mM L-glutamine, 100 U/ml of penicillin, and
100 μg/ml of streptomycin and 25 mM HEPES at 37°C
in a humidified chamber containing 95% air and 5%
CO2. Cell viability was assessed by trypan blue exclusion
test. Cell numbers were determined by hemocytometer.
To investigate the effects of plant extracts on T cell
proliferation, Jurkat T cells (0.1x106 cells/160 μl) were
suspended in RPMI-1640 without serum and seeded
in 96-well plate (Nunc, Roskilde, Denmark), then cells
were incubated for 46 h with increasing concentration
of plant extract solutions (5 μg.ml-1, 10 μg.ml-1 and
20 μg.ml-1), then stimulated with anti-CD3 antibody
(1 μg/well). Cells were distributed in six replicates as fol-
lows: 160 μl of cell suspension, 20 μl of sterile and
filtrated plant extract and 20 μl of anti-CD3 antibodies,
as previously described [9]. Plates were incubated for
46 h at 37°C in a 5% CO2/air atmosphere. For the last 6 -
hours, 0.8 μCi/well of (3H)-thymidine in 20 μL of RPMI-
1640 medium was added.
At the end of the incubation period, cells were col-
lected using a cell harvester (Dynatech, Burlington, MA,
USA), trapping their DNA onto glass filter-mats. When
the filter circles were dried, they were placed in plasticmini-vials (Packard, Downers Grove, IL, USA) and
added with 4 ml Optifluor-O (Packard). The radioactiv-
ity was recorded in a scintillation counter (Beckman,
Fullerton, CA, USA).
Determination of fatty acid composition in plants extracts
The details of the fatty acid composition of plant extracts
are presented in Table 2. Total lipids were extracted from
solutions of lyophilized plant extracts (1 mg/ml in physio-
logical saline solution) according to the method of Bligh
and Dyer [32], then transmethylated by BF3/methanol after
saponification, and fatty acids were analysed by gas liquid
chromatography [33], using C17:0 as internal standard,
with a Becker gas chromatograph (Becker instruments,
downers grove IL) equipped with a 50 m capillary glass col-
umn packed with carbowax 20 m (Spiral-RD, Couternon,
France). Analysis of fatty acid peaks was achieved with ref-
erence to the internal standard by using DELSI ENICA 21
integrator (Delsi Nermag, Rungis, France).
Statistical analysis
Values are mean ± SEM. Statistical analysis of data was
performed. Data were evaluated by analysis of variance.
Duncan's Multiple-Range test was employed for the
comparison. Differences were considered significant
when p < 0.05.
Table 2 Per cent of total fatty acid composition of plant extracts

































C14:0 0.0 1.4 ± 0.1 3.6 ± 0.1* 1.2 ±
0.09
8.0 ± 0.5* 8.8 ± 0.5* 0.0 0.0 3.4 ± 0.7* ND ND ND ND ND ND
C16:0 23.8 ± 1.2 44.2 ± 2.6* 51.4 ± 3.1* 2.0 ±
0.1
36.3 ± 1.6* 38.9 ± 4.0* 22.9 ± 1.2 4.5 ± 0.6* 54.9 ± 4.1* 27.3 ± 1.2 40.5 ± 2.9* 42.1 ± 3.9* 29.9 ± 2.3 0.0* 70.5 ± 4.9*
C18:0 7.4 ± 0.6 15.4 ± 1.5* 12.5 ± 0.9* 22.2 ±
1.9
38.6 ± 2.8* 11.2 ± 0.8* 4.4 ± 0.1 10.6 ± 1.2* 6.8 ± 0.6 9.5 + 1.2 22.6 ±1.6* 22.1 ± 1.7* 10.2 ± 1.2 21.3 ± 2.1* 13.4 ± 0.9
P
SFA 31.2 61.0 67.5 25.4 82.9 58.9 27.3 15.1 65.1 36.8 63.1 64.2 40.1 21.3 83.9
C16:1 3.7 ± 0.9 19.9 ± 1.5* 16.7 ± 0.8* 13.0±1.1* 0.0* 3.2 ± 0.1* 2.8 ± 0.08 51.0 ± 3.5* 12.0 ± 0.4* 9.3 ± 0.5 29.6 ± 2.5* 32.4 ± 0.9* 27.0 ± 3.3 60.6 ± 5.7* 16.1 ± 1.1*
C18:1 61.6 ± 1.9 13.0 ± 1.0* 8.6 ± 0.4* 17.4±1.1* 9.5 ± 0.7* 5.7 ± 0.9* 66.9 ± 1.6 22.4 ± 3.2* 10.2 ± 0.9* 52.0 + 3.8 5.5 ± 0.1* 1.9 ± 0.09* 32.9 ± 3.1 18.1 ± 1.0* 0.0
P
MUFA 65.3 32.9 25.3 30.4 9.5 8.9 69.7 73.4 22.2 61.3 35.1 34.3 59.9 78.7 16.1
C18:2n-6
(LA)
ND ND ND 16.5±1.0 7.6 ± 0.9* 15.9 ± 1.0 ND ND ND ND ND ND ND ND ND
C20:4n-6
(AA)




ND ND ND 16.5 7.6 15.9 ND ND ND ND ND ND ND ND ND
C18:3n-3
(LNA)
3.6 ± 0.2 6.1 ± 0.9* 7.1 ± 0.9* 27.6±2.5 ND 16.3 ± 1.1* 3.0 ± 0.2 11.5 ± 1.6* 12.8 ± 0.5* 1.9 ± 0.1 1.8 ± 0.2 1.5 ± 0.05 ND ND ND
C20:5n-3
(EPA)
ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND
C22:6n-3
(DHA)




3.6 6.1 7.1 27.6 ND 16.3 3.0 11.5 12.8 1.9 1.8 1.5 ND ND ND
Total FA 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Fatty acid compositions were determined as described in Methods section. Values are mean ± SEM. Each value represents the mean of three determinations. * p < 0.05 indicated significant differences as compared to
























Yessoufou et al. BMC Complementary and Alternative Medicine 2013, 13:77 Page 6 of 13
http://www.biomedcentral.com/1472-6882/13/77Results
Plant effects on glycemia and vitamin C levels during
diabetic pregnancy in rats
In the control animals treated with plant extracts, we
observed that glycemia was at normal level during preg-
nancy (Figures 1A, 1B, 1C). However, in diabetic ani
mals, Picralima and Nauclea butanolic extracts and
Oxytenanthera ethanolic extract induced a significant de-
crease of glycemia in diabetic pregnant rats from day16
until delivery on day21 (Figure 1B, C). Nonetheless,
Picralima ethanolic extract also significantly decreased the
glycemia though its value remained moderately high on
day21 in the diabetic animals (Figure 1C). The fifth ex-
tract, Nauclea ethanolic did not decrease glycemia in dia-
betic rats throughout pregnancy.
As far as plasma vitamin C concentration is concerned,
there was no significant difference in vitamin C concentra-
tions among plant-treated control rats and untreated con-
trol animals (Figure 2). However, in the diabetic groups,
highest level of vitamin C was observed in pregnant dia-
betic animals treated with vehicle or Nauclea-EtOH.
Plasma vitamin C levels were significantly lower in dia-
betic animals treated with insulin, Picra-but, Nauclea-but,
Oxy-EtOH, and Picra-EtOH extracts than in untreated
diabetic rats, but did not differ when compared with con-
trol animals.
Antioxidant capacity of plant extracts
Picralima butanolic extract exhibited the highest anti-
oxidant capacity; however in other extracts, this capacity
was similar to that of Nauclea (Figure 3). Oxytenanthera
showed appreciable and similar antioxidant activity in all
extracts, except in ethanolic and ether extracts where it
was respectively low and null. The order of the antioxi-
dant capacity is:
Picralima: . . .. . .. . .. . .. butanolic > ethanolic = ethyl
acetate = aqueous > ether
Nauclea: . . .. . .. . .. . .. . . butanolic = ethanolic = ethyl
acetate > aqueous = ether
Oxytenanthera: . . .. . .. butanolic = ethyl acetate =
aqueous > ethanolic > ether
The insert of Figure 3 represents the antioxidant activity
of aqueous extracts of the plants. It shows that the antioxi-
dant capacity of the plants was in a dose-dependent man-
ner. Based on this antioxidant capacity, we have selected
five plant extracts to test their efficacy in diabetic preg-
nancy in rats.
Concentration of vitamin C in different plant extracts
It is interesting to remark that all plant extracts showed
substantial content of vitamin C (Figure 4). However,
Picralima exhibited the lowest level of vitamin C.Vitamin C concentrations were quite similar in Nauclea
and Oxytenanthera.
Phytochemical composition of the extracts
Phythochemical analysis shows that Oxytenanthera
abyssinica and Picralima nitida are good sources of poly-
phenols (tannins, flavonoids, anthocyans and quinonic
derivates) and steroids (Oxytenanthera). Nauclea latifolia,
Oxytenanthera abyssinica and Picralima nitida are also
rich in alkaloids (Table 1).
Plant effects on human T cell proliferation
We used trypan blue exclusion test to assess the toxicity
of plant extracts on T cell viability. We observed that
plant extracts exhibited cytotoxic effect beyond the con-
centration of 50 μg/ml. Since no cytotoxic effect was ob-
served from 5 μg/ml to 20 μg/ml, we then used three
concentrations of plant extracts: 5 μg/ml, 10 μg/ml and
20 μg/ml.
The plant extracts significantly inhibited T cell prolifera-
tion activated by anti-CD3 antibody (Figure 5), in a
dose-dependent manner, except in cases of Picra-but and
Picra-aqueous which similarly inhibited T cell proliferation
at the three concentrations. The highest inhibitory effect
was observed at the concentration of 20 μg/ml with
Picra-EtoH. The insert of Figure 5 shows that in the
absence of anti-CD3 stimulation, plant extracts at concen-
tration of 20 μg/ml did not significantly influence T cell
proliferation.
Fatty acids composition in different plant extracts
General analysis of Table 2 shows that all of the plants
appeared to be good source of saturated (14:0, 16:0 and
18:0) and monounsaturated (16:1 and 18:1) fatty acids.
However, Nauclea latifolia and Oxytenanthera abyssinica
were richer in saturated fatty acids than Picralima nitida
which was richer in monounsaturated (16:1 and 18:1) fatty
acids than the former plants. Interestingly, none of the
plant extracts exhibited omega-6 polyunsaturated fatty
acids (like linoleic acid 18:2n-6 and arachidonic acid
20:4n-6) except ether extracts of all plants which curiously
exhibited substantial levels of linoleic acid (LA), the pre-
cursor of arachidonic acid (AA). Moreover, all plant ex-
tracts showed moderate level of linolenic acid (C18:3n-3),
except the residual aqueous fractions and ether fraction of
Nauclea latifolia. The three principal fatty acids (ie AA,
EPA and DHA) could not be detectable in none of the
plant extracts.
Discussion
More and more interest is now growing about plant use
as an alternative therapy for lowering blood glucose
levels in patients with diabetes mellitus. In the present

































































































































































































Figure 1 Glycemia in diabetic pregnant rats treated with plant extracts on day12 (A), day16 (B) and day21 (C) of gestation. Pregnant
rats were rendered diabetic by administration of five low doses of streptozotocin, starting on day5 of gestation. Lyophilised plant extracts diluted
in sterile physiological saline solution (NaCl 0.9%) were sterilized and filtrated [filter 0.20 μm (Nalge Nunc International Corp., USA)] and injected
intraperitoneally to diabetic or control animals from day12 to day15 of gestation (four days). Values are mean ± SEM. (§) p < 0.01 = significant
difference between diabetic rats compared with treated/untreated control animals. (*) p < 0.01 = significant difference between plant/insulin-
treated diabetic rats compared with untreated diabetic animals. NS = non-significant difference. A: Picra-EtOH: ethanolic fraction of Picralima
nitida; B: Picra-But: butaniolic fraction of Picralima nitida; C: Nauclea-EtOH: ethanolic fraction of Nauclea latifolia; D: Nauclea-But: butanolic fraction
of Nauclea latifolia; E: Oxy-EtOH: butanolic fraction of Oxytenanthera abyssinica.













































































































Figure 2 Plasma vitamin C concentration in control and
diabetic rats. Vitamin C concentration was determined in the
plasma of the control and diabetic animals at delivery (day21).
Values are mean ± SEM. (§) p < 0.01 = significant difference between
diabetic rats compared with treated/untreated control animals. (*) p
< 0.01 = significant difference between plant/insulin-treated diabetic
rats compared with untreated diabetic animals. NS = non-significant
difference. A: Picra-EtOH: ethanolic fraction of Picralima nitida; B:
Picra-But: butaniolic fraction of Picralima nitida; C: Nauclea-EtOH:
ethanolic fraction of Nauclea latifolia; D: Nauclea-But: butanolic
























































Figure 3 Antioxidant capacity of plant extracts. Antioxidant capacity of
in the Materials and Methods section. Results are mean ± SEM. Each value r
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diabetic pregnancy in rats. In this study, we induced a
mild type 1 diabetic pregnancy in wistar rats by
streptozotocin (STZ) injection. STZ when administered
at a high single dose induces diabetes by the direct toxic
effects on pancreatic β-islet cells [23]. However, when
STZ is administered at low doses during 5 consecutive
days, it induces mild type 1 diabetes, through a T-
lymphocyte-dependent process, an autoimmune destruc-
tion of pancreatic β cells mediated by both CD4+ and
CD8+ T cells [24,34]. Type 1 diabetic pregnancy induced
in pregnant rats starting on day 5 of gestation, mimick-
ing type 1 diabetes developed in human beings
[24,35,36], is also well established [19-22] and represents
a good model for several reasons [24,35,36]. Indeed, ma-
ternal STZ administration before pregnancy affects fer-
tility and impairs embryo development during the pre-
implantation period [37]. However, induction of diabetes
by STZ injection on day 5 of gestation has no effect on
embryo development [38].
In this study we observed that four different extracts















plant extracts was determined in a solution of 1 mg/ml as described












































Figure 4 Vitamin C concentration in plant extracts. Vitamin C
concentration was determined in a solution of 100 mg/ml of each
extract as described in the Materials and Methods section. Results are
mean ± SEM. Each value represents the mean of three determinations.
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http://www.biomedcentral.com/1472-6882/13/77pregnant diabetic animals. Ethanolic and butanolic extracts
of Picralima nitida, butanolic extract of Nauclea latifolia
and ethanolic extract of Oxytenanthera abyssinica signifi-
cantly decreased glycemia in diabetic animals, as compared
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Figure 5 Effects of plant extracts on T cell proliferation. Figure 5 show
represents the mean of six determinations. Values are the means ± SEM. (*) in
cells (p < 0.01). NS = non-significant difference. Figure 5 insert shows the effec
EtOH: ethanolic fraction of Picralima nitida; Picra-But: butaniolic fraction of Picr
But: butanolic fraction of Nauclea latifolia; Oxy-EtOH: butanolic fraction of Oxytare in accordance with those reported by Aguwa et al. [15]
and Inya-Agha et al. [16] who also demonstrated anti-
hyperglycemic effects of Picralima nitida in alloxan-
induced diabetic rats and rabbits. In contrast, Igboasoiyi et
al. [14] have reported that seed extract of Picralima nitida
did not possess hypoglycemic activity in alloxan-induced
diabetic rats. This discrepancy could be related to the
nature of solvent used and the mode of preparation of
the plant extracts. Indeed, anti-hyperglycemic effects
have been observed by Inya-Agha et al. [16] by treating
diabetic animals with methanolic extracts of pulp, rind
and seeds of Picralima nitida. Aguwa et al. [15] have
also observed positive effect by using aqueous seed ex-
tract of the plant in diabetic rabbits. However, Igboasoiyi
et al. [14], who did not observe any hypoglycemic activ-
ity in diabetic animals, have used total brut water extract
of seeds. It is noteworthy that plant extracts did not ei-
ther decrease or increase glycemia of the control ani-
mals, suggesting that plant extracts do not modulate
glycemia under normal condition. These observations
are in analogy to the results of some investigators who
have observed that Picralima nitida extract [14] or
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s the effects of plant extracts on human T cell proliferation. Each value
dicates significant difference compared with the only anti-CD3-stimulated
ts of different extracts at 20 μg/ml without stimulation by anti-CD3. Picra-
alima nitida; Nauclea-EtOH: ethanolic fraction of Nauclea latifolia; Nauclea-
enanthera abyssinica; Picra-Aqos: aqueous fraction of Picralima nitida.
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betic animals by these four extracts significantly dimin-
ished vitamin C concentration in the animals to the level
of those treated with insulin. Moreover, plasma vitamin C
concentrations were positively correlated with glycemia in
diabetic animals (R2 = 0.98). These observations may be
explained by the fact that L-ascorbate (vitamin C) is
known to be synthesized from glucose by D-glucuronic
acid pathway in mammals [40].
Beneficial effects of these plants may be related to the
presence of biologically active compounds [5,41]. We
have recently demonstrated that, Zizyphus lotus L.
(Desf.), a plant known for its antidiabetic properties is a
good source of antioxidant agents and its decoction ex-
erts immunosuppressive activities [9]. We observed that
extracts of Nauclea latifolia, Oxytenanthera abyssinica
and Picralima nitida exhibited substantial antioxidant
capacity. Picralima butanolic extract exerted the highest
antioxidant activity. It is possible that the antioxidant
activity might be due to the presence of vitamins. How-
ever, in the present study, there were not good correl-
ation between vitamin C levels and antioxidant activities
of plant extracts. Vitamin C levels were poorly corre-
lated with antioxidant activity in ethanolic (R2 = 0.28),
butanolic (R2 = 0.34) and ether (R2 = 0.04) extracts of
plants. In contrast, vitamin C was negatively correlated
with antioxidant activities in acetate (R2 = 0.97) and
aqueous (R2 = 0.99) extracts of plants. Our results did
not support those of Lenucci et al. [42] who have dem-
onstrated that antioxidant activity is likely to be due to
the presence of ascorbic acid, tocopherol and pigments.
It is also possible that the antioxidant activity of extracts
might be due to the presence of polyphenols as sug-
gested by Lamien-Meda et al. [43]. Indeed, our results
revealed that extracts of Oxytenanthera abyssinica and
Picralima nitida, which exhibited the highest antioxi-
dant capacity contained high level of polyphenols such
as tannins, flavonoids, anthocyans, leucoanthocyans and
quinonic derivates. These observations are in agreement
with the findings of some investigators who have re-
cently concluded that the high level of polyphenols in
the fruit of Zizyphus mauritania (L.) was responsible for
its antioxidant property [43].
Since antioxidants have been reported to modulate
immune system implicated in type 1 diabetes [27], we
examined the effects of the plant extracts on T cell pro-
liferation. We observed that all the analyzed extracts
(from the three plants) exerted an immunosuppressive
effect on T cell proliferation. Our results support our
previous findings [9] and those of Domingues et al. [44]
who have reported that aqueous-ethanol extract of
Uncaria tomentosa, a plant which belongs to the same
family with Nauclea latifolia (Rubiaceae) significantly
inhibited T lymphocyte proliferation and promotedimmunological polarization toward a Th2 cytokine
profile. Other investigators have also demonstrated the
antiiflammatory activity of Picralima nitida [11]. To our
knowledge, the present study is the first which investi-
gated and demonstrated the immunosuppressive action
of Oxytenanthera abyssinica on T cell proliferation.
In this study butanolic extract of Picralima nitida
appeared as the most potent immunosuppressor. At 10
and 20 μg/ml, the extract inhibited 94 ± 2.2% of T cell
proliferation while at the same concentrations the other
extracts inhibited T cell proliferation by 60.9 ± 7.6%
(Picra-EtOH), 51.5 ± 2.2% (Picra-aqeos), 75.3 ± 3.5%
(Nauclea-EtOH), 82.2 ± 2.9% (Nauclea-But) and 81.7 ±
8.5% (Oxy-EtOH). Generally, our results showed that
the most potent immunosuppressor extract, Picra-But
exhibited the most antioxidant activity, the most anti-
hyperglycemic effect in diabetic rats but the less vita-
min C content. These observations suggest that the
significant immunosuppressive effect of Picra-But can-
not be attributed to its content of vitamin C. Hence, it
is possible that fatty acids might be responsible of the
observed immunosuppressive effect. Indeed, among the
three plants tested on T cell proliferation P. nitida and
O. abyssinica are two richest plants that contains high
level of fatty acids and they contained notably the well-
known immunosuppressive omega-3 fatty acid, alpha-
linolenic acid (LNA, C18:3n-3), an essential fatty acid
and the precursor of eicosapentaenoic acid (EPA,
C20:5n-3) and docosahexaenoic acid (DHA, C22:6n-3).
It has been well established that n-3 fatty acids exert
immunosuppressive and anti-inflammatory activities
both in experimental and clinical studies [45]. In fact,
fatty acids have been found to interfere with cell signal-
ling particularly with the cascade of MAP kinases like
ERK1/2 and p38 [46]. In the same way, da Conceição
et al. [47] have shown that Genipa americana (a plant
of Rubiacea family) fruit extract inhibited the prolifera-
tion of human trophoblast-derived BeWo cells by
suppressing ERK and p38 MAPKs phosphorylation.
However in the present study, it is noteworthy that the
plant extracts, without mitogen stimulation, failed to
inhibit cell proliferation suggesting that plant extracts
do not influence T-cell proliferation under normal con-
ditions. These results are in analogy to our previous
observations that feeding omega-3 fatty acid enriched-
diet to control animals did not significantly influence
T-cell proliferation [19,20].
On the other hand, the immunosuppressive activity
might also be attributed to the alkaloids contained in the
plants. Our study showed that all of the plants (Nauclea,
Picralima and Oxytenanthera), whose extracts exhibited
a significant immunosuppressive action contained good
level of alkaloids. Indeed, Duwiejua et al. [11] have demon-
strated that pseudo-akuammigine, an alkaloid isolated from
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and analgesic activity. Moreover, Bacher et al. [48] have
demonstrated that oxindole alkaloids obtained from
Uncaria tomentosa (a South American Rubiaceae) inhibited
proliferation of acute lymphoblastic leukaemia cells.
The mechanism of action is likely to be that alkaloids
in plants could interfere with T cell cycle. Indeed, an
alkaloid-rich extract derived from Nauclea latifolia
could interact in vitro with DNA of bacteria and mam-
malian cells leading to G2-M cell cycle arrest and herit-
able DNA-damage, as well as inducing in vivo single-
strand breaks in liver, kidney and blood cells [49]. The
findings by Mesaik et al. [50] have revealed that steroidal
alkaloids from Buxus hyrcana exhibited suppressive
effect on the phytohemagglutinin-stimulated T-cell pro-
liferation, and that docking results revealed that these
two alkaloids adopt a similar binding pattern at the ac-
tive site of the IL-2. Yuan et al. [51] have demonstrated
that rhynchophylline and isorhynchophylline, a pair of
isomeric alkaloids of Uncaria rhynchophylla (a plant of
Rubiacea family) suppressed phosphorylation of ERK
and p38 MAPKs in microglial cells. Thus, by interfering
with T cell cycle, alkaloids from antidiabetic plants could
inhibit auto-reactive T cells, which lead to autoimmune
type 1 diabetes.
Conclusion
To our knowledge, the present study is the first carried
out on the efficacy of antidiadetic plants in diabetic
pregnancy. Different extracts of Nauclea latifolia,
Picralima nitida and Oxytenanthera abyssinica bear
potential therapeutic properties in diabetes and diabetic
pregnancy as they possess antioxidant, anti-hyperglycemic
and immunosuppressive activities. However, further
studies are required to elucidate the effects of different
extracts of plants in the modulation of different param-
eters related to diabetic pregnancy and autoimmune
diseases.
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